NYTimes -- The pharmaceutical industry glimpsed its own ghost this week, and the apparition could not have arrived at a worse time for drug makers. A report indicating that Merck used ghostwriters to produce medical journal articles in support of its subsequently discredited drug Vioxx has galvanized opponents to a federal proposal that would relax some restrictions on drug promotion.
